Insiders Kymera Therapeutics, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 11:48:03 14/05/2024 pm IST			5-day change	1st Jan Change
35.46 ^USD	-7.56%		-9.70%	+36.33%

03/05	Oppenheimer Adjusts Kymera Therapeutics Price Target to $52 From $53	MT
02/05	Kymera Therapeutics Q1 Net Loss Narrows, Collaboration Revenue Rises	MT

Kymera Therapeutics, Inc. Appoints Felix J. Baker to the Board	01/04	CI
Kymera Therapeutics Insider Sold Shares Worth $14,912,376, According to a Recent SEC Filing	14/03	MT
Kymera Therapeutics Insider Sold Shares Worth $300,470, According to a Recent SEC Filing	24/01	MT
Kymera Therapeutics Appoints Jeremy Chadwick COO	22/23/22	MT
Kymera Appoints Jeremy Chadwick as Chief Operating Officer	22/23/22	CI
Kymera Therapeutics, Inc. Announces Departure of Elaine Caughey as Chief Business Officer	28/23/28	CI
Insider Sell: Kymera Therapeutics	17/23/17	MT
Kymera Therapeutics, Inc. Appoints Ellen Chiniara, J.D., as Chief Legal Officer and Corporate Secretary	04/23/04	CI
Insider Sell: Kymera Therapeutics	17/22/17	MT
Insider Sell: Kymera Therapeutics	05/22/05	MT
Kymera Therapeutics, Inc. Announces Management Changes	03/22/03	CI
Insider Sell: Kymera Therapeutics	02/22/02	MT
Kymera Therapeutics, Inc. Appoints Leigh Morgan to its Board of Directors	08/22/08	CI
Kymera Therapeutics, Inc. Announces Executive Change	12/22/12	CI
Kymera Therapeutics Appoints Healthcare Industry Leader John Maraganore, Ph.D., to Board of Directors	18/22/18	CI
Insider Sell: Kymera Therapeutics	13/22/13	MT
Kymera Therapeutics, Inc. Appoints Vijay Sabesan as Senior Vice President, Technical Operations	06/21/06	CI
Insider Sell: Kymera Therapeutics	03/21/03	MT
Insider Sell: Kymera Therapeutics	13/21/13	MT
Kymera Therapeutics : Chief Scientific Officer Chesworth to Depart Next Month -- Shares Drop in Late Hours Trading	17/21/17	MT

No results for this search